Why inflammation can outlast intensive care
An ICU discharge marks a change in where care happens, not necessarily the end of the body’s response to illness. Severe infection, surgery, injury, and other critical conditions can activate the immune system. Treatment and intensive care may add further physical stress. As the body repairs damage, inflammatory signals can remain active even after the immediate crisis has passed.
Some of those signals are proteins released into the blood. A blood test can measure their levels, offering clinicians one way to follow how inflammatory activity changes during recovery. A result that stays elevated for weeks may reflect a response that has not fully settled; it is a clue to consider alongside symptoms and other findings, not a diagnosis on its own.
What the signal can—and cannot—tell doctors
Post-intensive care syndrome, or PICS, describes new or worsened physical, cognitive, or mental-health problems that can persist after critical illness. Lingering inflammation may be part of the complex recovery picture, but a blood marker does not reveal by itself whether someone has PICS, what symptoms they will develop, or what caused them. The same result can have different meanings depending on the person’s illness and overall condition.
That is why trends can matter more than a single number. Clinicians can interpret a biomarker alongside changes in strength, thinking, mood, and other aspects of health, then decide whether recovery needs closer attention. For survivors, the practical point is that leaving the ICU may begin a longer phase of healing—and that measurable biological changes can persist during it.
